Toxicities of Intensity-Modulated Radiotherapy with or Without Pelvic Nodal Irradiation in Patients with Localized Prostate Cancer:A Comparative Study

刘跃平,李晔雄,王维虎,金晶,房辉,王淑莲,宋永文,任骅,刘新帆

DOI: https://doi.org/10.3760/cma.j.issn.1004-4221.2013.03.005

2013-01-01

Abstract:Objective To analyze the acute and late intestinal and genitourinary toxicities of intensity-modulated radiotherapy (IMRT) with or without pelvic nodal irradiation in patients with localized prostate cancer.Methods Eighty-three patients with pelvic-confined prostate cancer,who received radical IMRT between February 2009 and March 2012,were included in the study.Of them,38 low-and mediumrisk patients received hypofractionated IMRT (67.5 Gy) to the prostate (and seminal vesicles),and 45 high-risk patients or patients who had an assessed risk of pelvic lymph node metastasis above 15％ received hypofractionated IMRT (67.5 Gy) to the prostate and seminal vesicles as well as prophylactic irradiation (50 Gy) to the pelvic lymph nodes.The gastrointestinal and genitourinary toxieities were evaluated during and after radiotherapy.Acute toxicities were graded according to common terminology criteria for adverse events,version 3.0,while late toxicities were graded according to the toxicity criteria of the radiation therapy oncology group.Results Of the patients receiving pelvic nodal irradiation,27％ and 0％ experienced grade 2 and 3 acute gastrointestinal toxicities,versus 5％ and 3％ of those not receiving pelvic nodal irradiation (P =0.025) ;11％ and 9％ of the patients receiving pelvic nodal irradiation experienced grade 2 and 3 late gastrointestinal toxicities,versus 29％ and 3％ of those not receiving pelvic nodal irradiation (P =0.170).Of the patients receiving pelvic nodal irradiation,13％ and 0％ experienced grade 2 and 3 acute genitourinary toxicities,versus 16％ and 3％ of those not receiving pelvic nodal irradiation (P =0.368) ;9％ and 2％ of the patients receiving pelvic nodal irradiation experienced grade 2 and 3 late genitourinary toxicities,versus 24％ and 3％ of those not receiving pelvic nodal irradiation (P =0.066).Conclusions Pelvic nodal irradiation during IMRT increases the incidence of acute gastrointestinal toxicity in patients with prostate cancer,but it does not increase the incidence of late gastrointestinal and genitourinary toxicities.